Personal information

Other IDs

Loop profile: 681023

Activities

Collapse all

Professional activities (1)

University of Rome Tor Vergata: Rome, Lazio, IT

2022-03-31 to present | Assistant Professor (Department of the Systems Medicine)
Invited position
Source: Self-asserted source
Doriana Landi

Works (50 of 81)

Items per page:
Page 1 of 2

Topographical Correlation between Structural and Functional Impairment of the Macular Inner Retinal Layers in Multiple Sclerosis Eyes with a History of Optic Neuropathy

Journal of Clinical Medicine
2023-11 | Journal article | Author
DOI: 10.3390/jcm12227175
Contributors: Vincenzo Parisi; Lucilla Barbano; giulio antonelli; Carolina Gabri Nicoletti; Doriana Landi; Giorgia Mataluni; Antonio Di Renzo; Fabio Buttari; Girolama Alessandra Marfia; Diego Centonze et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Ovarian reserve in patients with multiple sclerosis: A systematic review and meta-analysis.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
2023-04 | Journal article
DOI: 10.1002/ijgo.14757
PMID: 37017322
Contributors: Carbone L; Di Girolamo R; Conforti A; Iorio GG; Simeon V; Landi D; Marfia GA; Lanzillo R; Alviggi C
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

A specific anti-COVID-19 BNT162b2 vaccine-induced early innate immune signature positively correlates with the humoral protective response in healthy and multiple sclerosis vaccine recipients.

Clinical & translational immunology
2023-03 | Journal article
DOI: 10.1002/cti2.1434
PMID: 36969367
PMC: PMC10036198
Contributors: Severa M; Rizzo F; Sinigaglia A; Ricci D; Etna MP; Cola G; Landi D; Buscarinu MC; Valdarchi C; Ristori G et al.
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

COVID-19 vaccine hesitancy among Italian people with multiple sclerosis.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2022-12 | Journal article
DOI: 10.1007/s10072-022-06559-x
PMID: 36567409
PMC: PMC9790761
Contributors: Proietti F; Landi D; Ponzano M; Cola G; Di Mauro G; Mataluni G; Nicoletti CG; Curcio G; Marfia GA
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

Association of vitamin D serum levels and vitamin D supplementation with B cell kinetics and disease activity in Multiple Sclerosis patients treated with ocrelizumab: an Italian multi-center study.

Multiple sclerosis and related disorders
2022-11 | Journal article
DOI: 10.1016/j.msard.2022.104395
PMID: 36544324
Contributors: Miele G; Abbadessa G; Cavalla P; Valentino P; Marfia GA; Landi D; Bosa C; Vercellino M; De Martino A; Ponzano M et al.
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis.

Journal of neurology, neurosurgery, and psychiatry
2022-09 | Journal article
DOI: 10.1136/jnnp-2022-329657
PMID: 36180219
Contributors: Landi D; Bovis F; Grimaldi A; Annovazzi PO; Bertolotto A; Bianchi A; Borriello G; Brescia Morra V; Bucello S; Buscarinu MC et al.
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

Signs and symptoms of COVID-19 in patients with multiple sclerosis.

European journal of neurology
2022-09 | Journal article
DOI: 10.1111/ene.15554
PMID: 36086905
PMC: PMC9538224
Contributors: Schiavetti I; Carmisciano L; Ponzano M; Cordioli C; Cocco E; Marfia GA; Inglese M; Filippi M; Radaelli M; Bergamaschi R et al.
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

Skin Thickening of the Scalp and High Signal Intensity of Dentate Nucleus in Multiple Sclerosis: Association With Linear Versus Macrocyclic Gadolinium-Based Contrast Agents Administration.

Investigative radiology
2022-09 | Journal article
DOI: 10.1097/rli.0000000000000929
PMID: 36729383
Contributors: Quattrocchi CC; Parillo M; Spani F; Landi D; Cola G; Dianzani C; Perrella E; Marfia GA; Mallio CA
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study.

Neurology and therapy
2022-06 | Journal article
DOI: 10.1007/s40120-022-00364-6
PMID: 35653061
PMC: PMC9338179
Contributors: Petracca M; Ruggieri S; Barbuti E; Ianniello A; Fantozzi R; Maniscalco GT; Andreone V; Landi D; Marfia GA; Di Gregorio M et al.
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis.

Multiple sclerosis and related disorders
2022-05 | Journal article
DOI: 10.1016/j.msard.2022.103909
PMID: 35675744
PMC: PMC9130313
Contributors: Ponzano M; Schiavetti I; Bovis F; Landi D; Carmisciano L; De Rossi N; Cordioli C; Moiola L; Radaelli M; Immovilli P et al.
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy.

EBioMedicine
2022-05 | Journal article
DOI: 10.1016/j.ebiom.2022.104042
PMID: 35526306
PMC: PMC9069178
Contributors: Sormani MP; Schiavetti I; Inglese M; Carmisciano L; Laroni A; Lapucci C; Visconti V; Serrati C; Gandoglia I; Tassinari T et al.
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

Multifocal Electroretinogram Photopic Negative Response: A Reliable Paradigm to Detect Localized Retinal Ganglion Cells’ Impairment in Retrobulbar Optic Neuritis Due to Multiple Sclerosis as a Model of Retinal Neurodegeneration

Diagnostics
2022-05 | Journal article | Author
DOI: 10.3390/diagnostics12051156
Contributors: Lucilla Barbano; Lucia Ziccardi; Giulio Antonelli; Carolina Gabri Nicoletti; Doriana Landi; Giorgia Mataluni; Benedetto Falsini; Girolama Alessandra Marfia; Diego Centonze; Vincenzo Parisi
Source: check_circle
Multidisciplinary Digital Publishing Institute

Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab.

Neurology(R) neuroimmunology & neuroinflammation
2022-03 | Journal article
DOI: 10.1212/nxi.0000000000001157
PMID: 35273036
PMC: PMC9005049
Contributors: Landi D; Grimaldi A; Bovis F; Ponzano M; Fantozzi R; Buttari F; Signoriello E; Lus G; Lucchini M; Mirabella M et al.
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications.

Frontiers in immunology
2022-01 | Journal article
DOI: 10.3389/fimmu.2021.796482
PMID: 35111162
PMC: PMC8801814
Contributors: Iannetta M; Landi D; Cola G; Campogiani L; Malagnino V; Teti E; Coppola L; Di Lorenzo A; Fraboni D; Buccisano F et al.
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

Diagnostic Value of JC Polyomavirus Viruria, Viremia, Serostatus and microRNA Expression in Multiple Sclerosis Patients Undergoing Immunosuppressive Treatment

Journal of Clinical Medicine
2022-01 | Journal article | Author
DOI: 10.3390/jcm11020347
Contributors: CARLA PREZIOSO; Marco Ciotti; Gabriele Brazzini; Francesca Piacentini; Sara Passerini; Alfonso Grimaldi; Doriana Landi; Carolina Gabri Nicoletti; Maria Antonella Zingaropoli; Marco Iannetta et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies

2021-12 | Preprint
DOI: 10.1101/2021.12.23.21268177
PPR: PPR436970
Contributors: Sormani MP; Schiavetti I; Inglese M; Carmisciano L; Laroni A; Lapucci C; Visconti V; Serrati C; Gandoglia I; Tassinari T et al.
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

Correction to: Validity of the Italian multiple sclerosis neuropsychological screening questionnaire.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2021-11 | Journal article
DOI: 10.1007/s10072-021-05168-4
PMID: 33704600
Contributors: Migliore S; Landi D; Proietti F; D'Aurizio G; Squitieri F; Mataluni G; Nicoletti CG; Curcio G; Marfia GA
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis.

European journal of neurology
2021-11 | Journal article
DOI: 10.1111/ene.15167
PMID: 34735749
PMC: PMC8652772
Contributors: Bergamaschi R; Ponzano M; Schiavetti I; Carmisciano L; Cordioli C; Filippi M; Radaelli M; Immovilli P; Capobianco M; De Rossi N et al.
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

Anti-HBs titers are not decreased after treatment with oral Cladribine in patients with Multiple Sclerosis vaccinated against Hepatitis B virus.

Multiple sclerosis and related disorders
2021-10 | Journal article
DOI: 10.1016/j.msard.2021.103334
PMID: 35158447
Contributors: Landi D; Nicoletti CG; Di Mauro G; Cola G; Grimaldi A; Mataluni G; Marfia GA
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

Complex Rearrangement of the Entire Retinal Posterior Pole in Patients with Relapsing Remitting Multiple Sclerosis

Journal of Clinical Medicine
2021-10 | Journal article | Author
DOI: 10.3390/jcm10204693
Contributors: Alessio Martucci; Doriana Landi; Massimo Cesareo; emiliano di carlo; Giovanni Di Mauro; Roberto Pietro Sorge; Maria Albanese; Carolina Gabri Nicoletti; Giorgia Mataluni; Nicola Biagio Mercuri et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Safety of Natalizumab infusion in multiple sclerosis patients during active SARS-CoV-2 infection.

Multiple sclerosis and related disorders
2021-10 | Journal article
DOI: 10.1016/j.msard.2021.103345
PMID: 35158454
PMC: PMC8542399
Contributors: Landi D; Cola G; Mantero V; Balgera R; Moiola L; Nozzolillo A; Dattola V; Sinisi L; Fantozzi R; Di Lemme S et al.
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies.

EBioMedicine
2021-09 | Journal article
DOI: 10.1016/j.ebiom.2021.103581
PMID: 34563483
PMC: PMC8456129
Contributors: Sormani MP; Inglese M; Schiavetti I; Carmisciano L; Laroni A; Lapucci C; Da Rin G; Serrati C; Gandoglia I; Tassinari T et al.
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

CD19 Cell Count at Baseline Predicts B Cell Repopulation at 6 and 12 Months in Multiple Sclerosis Patients Treated with Ocrelizumab

International Journal of Environmental Research and Public Health
2021-08 | Journal article | Author
DOI: 10.3390/ijerph18158163
Contributors: Gianmarco Abbadessa; Giuseppina Miele; Paola Cavalla; Paola Valentino; Girolama Alessandra Marfia; Elisabetta Signoriello; Doriana Landi; Chiara Bosa; Marco Vercellino; Antonio De Martino et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Risk Assessment of Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis Patients during 1 Year of Ocrelizumab Treatment.

Viruses
2021-08 | Journal article
DOI: 10.3390/v13091684
PMID: 34578264
PMC: PMC8473394
Contributors: Prezioso C; Grimaldi A; Landi D; Nicoletti CG; Brazzini G; Piacentini F; Passerini S; Limongi D; Ciotti M; Palamara AT et al.
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France.

Annals of clinical and translational neurology
2021-07 | Journal article
DOI: 10.1002/acn3.51408
PMID: 34240579
PMC: PMC8351392
Contributors: Sormani MP; Salvetti M; Labauge P; Schiavetti I; Zephir H; Carmisciano L; Bensa C; De Rossi N; Pelletier J; Cordioli C et al.
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

Effect of SARS-CoV-2 mRNA Vaccination in MS Patients Treated With Disease Modifying Therapies

2021-07 | Preprint
DOI: 10.2139/ssrn.3886420
PPR: PPR373357
Contributors: Sormani MP; Inglese M; Schiavetti I; Carmisciano L; Laroni A; Lapucci C; Rin GD; Serrati C; Gandoglia I; Tassinari T et al.
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

Patient's point of view on the use of telemedicine in multiple sclerosis: a web-based survey.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2021-07 | Journal article
DOI: 10.1007/s10072-021-05398-6
PMID: 34283343
PMC: PMC8289711
Contributors: Landi D; Ponzano M; Nicoletti CG; Cola G; Cecchi G; Grimaldi A; Mataluni G; Mercuri NB; Sormani MP; Pacileo G et al.
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study.

Multiple sclerosis (Houndmills, Basingstoke, England)
2021-07 | Journal article
DOI: 10.1177/13524585211035318
PMID: 34328824
Contributors: Sormani MP; Schiavetti I; Landi D; Carmisciano L; De Rossi N; Cordioli C; Moiola L; Radaelli M; Immovilli P; Capobianco M et al.
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

T-cell responses to SARS-CoV-2 in multiple sclerosis patients treated with ocrelizumab healed from COVID-19 with absent or low anti-spike antibody titers.

Multiple sclerosis and related disorders
2021-07 | Journal article
DOI: 10.1016/j.msard.2021.103157
PMID: 34418737
PMC: PMC8291995
Contributors: Iannetta M; Landi D; Cola G; Malagnino V; Teti E; Fraboni D; Buccisano F; Grelli S; Coppola L; Campogiani L et al.
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

Assessment of Macular Function by Multifocal Electroretinogram in Patients with Multiple Sclerosis Treated with Fingolimod.

Advances in therapy
2021-06 | Journal article
DOI: 10.1007/s12325-021-01728-4
PMID: 34109558
PMC: PMC8280030
Contributors: Barbano L; Ziccardi L; Landi D; Nicoletti CG; Mataluni G; Falsini B; Centonze D; Marfia GA; Quaranta L; Parisi V
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

What happens after fingolimod discontinuation? A multicentre real-life experience.

Journal of neurology
2021-06 | Journal article
DOI: 10.1007/s00415-021-10658-8
PMID: 34136943
Contributors: Landi D; Signori A; Cellerino M; Fenu G; Nicoletti CG; Ponzano M; Mancuso E; Fronza M; Ricchiuto ME; Boffa G et al.
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

Switch from sequestering to anti-CD20 depleting treatment: disease activity outcomes during wash-out and in the first 6 months of ocrelizumab therapy.

Multiple sclerosis (Houndmills, Basingstoke, England)
2021-04 | Journal article
DOI: 10.1177/13524585211005657
PMID: 33855897
Contributors: Signoriello E; Lus G; Bonavita S; Lanzillo R; Saccà F; Landi D; Frau J; Baroncini D; Zaffaroni M; Maniscalco GT et al.
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

Choriocapillaris Integrity in Relapsed Central Serous Chorioretinopathy in a Patient Treated With Fingolimod for Multiple Sclerosis: New Insights From Optical Coherence Tomography Angiography.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
2021-03 | Journal article
DOI: 10.1097/wno.0000000000000937
PMID: 32235227
Contributors: Ziccardi L; Landi D; De Geronimo D; Barbano L; Giorno P; Marfia GA; Albanese M; Parisi V; Parravano M
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study.

Journal of the neurological sciences
2021-03 | Journal article
DOI: 10.1016/j.jns.2021.117385
PMID: 33770708
Contributors: De Mercanti SF; Signori A; Cordioli C; Signoriello E; Lus G; Bonavita S; Abbadessa G; Lavorgna L; Maniscalco GT; Curti E et al.
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

Validity of the Italian multiple sclerosis neuropsychological screening questionnaire.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2021-03 | Journal article
DOI: 10.1007/s10072-021-05141-1
PMID: 33651198
Contributors: Migliore S; Landi D; Proietti F; D'Aurizio G; Squitieri F; Mataluni G; Nicoletti CG; Curcio G; Marfia GA
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis.

Annals of neurology
2021-02 | Journal article
DOI: 10.1002/ana.26028
PMID: 33480077
PMC: PMC8013440
Contributors: Sormani MP; De Rossi N; Schiavetti I; Carmisciano L; Cordioli C; Moiola L; Radaelli M; Immovilli P; Capobianco M; Trojano M et al.
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study.

Journal of neurology
2021-02 | Journal article
DOI: 10.1007/s00415-021-10455-3
PMID: 33616742
Contributors: Bucello S; Annovazzi P; Ragonese P; Altieri M; Barcella V; Bergamaschi R; Bianchi A; Borriello G; Buscarinu MC; Callari G et al.
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study.

European journal of neurology
2021-01 | Journal article
DOI: 10.1111/ene.14672
PMID: 33305459
Contributors: Di Gregorio M; Torri Clerici VLA; Fenu G; Gaetani L; Gallo A; Cavalla P; Ragonese P; Annovazzi P; Gajofatto A; Prosperini L et al.
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosis.

Journal of neurology
2021-01 | Journal article
DOI: 10.1007/s00415-021-10412-0
PMID: 33496861
PMC: PMC8179888
Contributors: Lucchini M; Prosperini L; Buscarinu MC; Centonze D; Conte A; Cortese A; Elia G; Fantozzi R; Ferraro E; Gasperini C et al.
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

Functional Assessment of Outer and Middle Macular Layers in Multiple Sclerosis.

Journal of clinical medicine
2020-11 | Journal article
DOI: 10.3390/jcm9113766
PMID: 33266435
PMC: PMC7700336
Contributors: Ziccardi L; Barbano L; Boffa L; Albanese M; Nicoletti CG; Landi D; Grzybowski A; Falsini B; Marfia GA; Centonze D et al.
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

Cladribine vs other drugs in MS: Merging randomized trial with real-life data.

Neurology(R) neuroimmunology & neuroinflammation
2020-08 | Journal article
DOI: 10.1212/nxi.0000000000000878
PMID: 32801167
PMC: PMC7641098
Contributors: Signori A; Saccà F; Lanzillo R; Maniscalco GT; Signoriello E; Repice AM; Annovazzi P; Baroncini D; Clerico M; Binello E et al.
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

COVID-19: dealing with a potential risk factor for chronic neurological disorders.

Journal of neurology
2020-08 | Journal article
DOI: 10.1007/s00415-020-10131-y
PMID: 32852580
PMC: PMC7450256
Contributors: Schirinzi T; Landi D; Liguori C
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

Mild clinical manifestations of SARS-CoV-2 related pneumonia in two patients with multiple sclerosis under treatment with ocrelizumab.

Multiple sclerosis and related disorders
2020-08 | Journal article
DOI: 10.1016/j.msard.2020.102442
PMID: 32777745
PMC: PMC7399651
Contributors: Iannetta M; Cesta N; Stingone C; Malagnino V; Teti E; Vitale P; De Simone G; Rossi B; Ansaldo L; Compagno M et al.
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

Adherence to social distancing and use of personal protective equipment and the risk of SARS-CoV-2 infection in a cohort of patients with multiple sclerosis.

Multiple sclerosis and related disorders
2020-07 | Journal article
DOI: 10.1016/j.msard.2020.102359
PMID: 32663793
PMC: PMC7333605
Contributors: Landi D; Ponzano M; Nicoletti CG; Cecchi G; Cola G; Mataluni G; Mercuri NB; Sormani MP; Marfia GA
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

Sex effects across the lifespan in women with multiple sclerosis.

Therapeutic advances in neurological disorders
2020-07 | Journal article
DOI: 10.1177/1756286420936166
PMID: 32655689
PMC: PMC7331774
Contributors: Krysko KM; Graves JS; Dobson R; Altintas A; Amato MP; Bernard J; Bonavita S; Bove R; Cavalla P; Clerico M et al.
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

Exposure to natalizumab during pregnancy and lactation is safe - Yes.

Multiple sclerosis (Houndmills, Basingstoke, England)
2020-06 | Journal article
DOI: 10.1177/1352458520915814
PMID: 32508253
Contributors: Landi D; Marfia GA
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian study.

Multiple sclerosis and related disorders
2020-03 | Journal article
DOI: 10.1016/j.msard.2020.102059
PMID: 32208344
Contributors: Maniscalco GT; Saccà F; Lanzillo R; Annovazzi P; Baroncini D; Binello E; Repice A; Perini P; Clerico M; Mataluni G et al.
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved?

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
2020-01 | Journal article
DOI: 10.1007/s13311-019-00776-7
PMID: 31452081
PMC: PMC7007494
Contributors: Clerico M; De Mercanti SF; Signori A; Iudicello M; Cordioli C; Signoriello E; Lus G; Bonavita S; Lavorgna L; Maniscalco GT et al.
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

Exit strategies for "needle fatigue" in multiple sclerosis: a propensity score-matched comparison study.

Journal of neurology
2019-11 | Journal article
DOI: 10.1007/s00415-019-09625-1
PMID: 31720848
Contributors: Prosperini L; Cortese A; Lucchini M; Boffa L; Borriello G; Buscarinu MC; Capone F; Centonze D; De Fino C; De Pascalis D et al.
Source: Self-asserted source
Doriana Landi via Europe PubMed Central

Treatment with Dimethyl Fumarate Enhances Cholinergic Transmission in Multiple Sclerosis.

CNS drugs
2019-11 | Journal article
DOI: 10.1007/s40263-019-00676-6
PMID: 31650471
Contributors: Nicoletti CG; Landi D; Monteleone F; Mataluni G; Albanese M; Lauretti B; Rocchi C; Simonelli I; Boffa L; Buttari F et al.
Source: Self-asserted source
Doriana Landi via Europe PubMed Central
Items per page:
Page 1 of 2

Peer review (3 reviews for 3 publications/grants)

Review activity for Journal of neurology. (1)
Review activity for Neurological sciences. (1)
Review activity for PloS one. (1)
How many people are using ORCID?